Biotech Growth N V - Net Worth and Insider Trading
Biotech Growth N V Net Worth
The estimated net worth of Biotech Growth N V is at least $322 Million dollars as of 2024-04-28. Biotech Growth N V is the 10% Owner of Radius Health Inc and owns about 6,881,685 shares of Radius Health Inc (RDUS) stock worth over $223 Million. Biotech Growth N V is the 10% Owner of Black Diamond Therapeutics Inc and owns about 8,517,839 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $50 Million. Biotech Growth N V is also the 10% Owner of ESSA Pharma Inc and owns about 7,879,583 shares of ESSA Pharma Inc (EPIX) stock worth over $48 Million. Details can be seen in Biotech Growth N V's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biotech Growth N V has not made any transactions after 2023-10-17 and currently still holds the listed stock(s).
Transaction Summary of Biotech Growth N V
Biotech Growth N V Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotech Growth N V owns 3 companies in total, including Radius Health Inc (RDUS) , ESSA Pharma Inc (EPIX) , and Black Diamond Therapeutics Inc (BDTX) .
Click here to see the complete history of Biotech Growth N V’s form 4 insider trades.
Insider Ownership Summary of Biotech Growth N V
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RDUS | Radius Health Inc | 2019-11-06 | 10 percent owner |
| EPIX | ESSA Pharma Inc | 2022-10-27 | 10 percent owner |
| BDTX | Black Diamond Therapeutics Inc | 2023-10-17 | 10 percent owner |
Biotech Growth N V Latest Holdings Summary
Biotech Growth N V currently owns a total of 3 stocks. Among these stocks, Biotech Growth N V owns 6,881,685 shares of Radius Health Inc (RDUS) as of November 6, 2019, with a value of $223 Million and a weighting of 69.5%. Biotech Growth N V owns 8,517,839 shares of Black Diamond Therapeutics Inc (BDTX) as of October 17, 2023, with a value of $50 Million and a weighting of 15.6%. Biotech Growth N V also owns 7,879,583 shares of ESSA Pharma Inc (EPIX) as of October 27, 2022, with a value of $48 Million and a weighting of 14.9%.
Latest Holdings of Biotech Growth N V
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2019-11-06 | 6,881,685 | 32.47 | 223,448,312 |
| BDTX | Black Diamond Therapeutics Inc | 2023-10-17 | 8,517,839 | 5.89 | 50,170,072 |
| EPIX | ESSA Pharma Inc | 2022-10-27 | 7,879,583 | 6.08 | 47,907,865 |
Holding Weightings of Biotech Growth N V
Biotech Growth N V Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 1 transactions in Radius Health Inc (RDUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Radius Health Inc is the acquisition of 100,000 shares on November 6, 2019, which cost Biotech Growth N V around $2 Million.
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 10 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Black Diamond Therapeutics Inc is the acquisition of 400,000 shares on October 17, 2023, which cost Biotech Growth N V around $936,000.
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 5 transactions in ESSA Pharma Inc (EPIX) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in ESSA Pharma Inc is the acquisition of 2,000,000 shares on October 27, 2022, which cost Biotech Growth N V around $8 Million.
Insider Trading History of Biotech Growth N V
- 1
Biotech Growth N V Trading Performance
GuruFocus tracks the stock performance after each of Biotech Growth N V's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Growth N V is 6.64%. GuruFocus also compares Biotech Growth N V's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Growth N V within 3 months outperforms 29 times out of 60 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biotech Growth N V's insider trading performs compared to the benchmark.
Performance of Biotech Growth N V
Average Return
-16.98%
Outperforming Transactions
18%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.95 | 6.64 | -7.77 | -16.98 | -16.25 | -21.1 |
| Relative Return to S&P 500(%) | -2.37 | 4.07 | -11.36 | -25.94 | -25.41 | -31.88 |
Biotech Growth N V Ownership Network
Ownership Network List of Biotech Growth N V
Ownership Network Relation of Biotech Growth N V
Biotech Growth N V Owned Company Details
What does Radius Health Inc do?
Who are the key executives at Radius Health Inc?
Biotech Growth N V is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .
Radius Health Inc (RDUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Radius Health Inc Insider Transactions
Biotech Growth N V Mailing Address
Above is the net worth, insider trading, and ownership report for Biotech Growth N V. You might contact Biotech Growth N V via mailing address: Ara Hill Top Building, Unit A-5, Pletterijweg Oost 1, Curacao, Willemstad P8 000000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
